Top Markets
Coin of the day
Middle East Pharmaceutical Industries Company Middle East Pharmaceutical Industries Company

Middle East Pharmaceutical Industries Company

4016
Rang in aandelen #12214
Middle East Pharmaceutical Industries Company (MEPIC), established in Riyadh,... Middle East Pharmaceutical Industries Company (MEPIC), established in Riyadh, Saudi Arabia, in 1998, is a global pharmaceutical entity. The company's core activities encompass the entire lifecycle of generic medicines and various pharmaceutical products, from research and development to manufacturing and sales, catering to both local and international markets. Its business operations are strategically divided into private sector, public sector, and export divisions. MEPIC offers an extensive array of products designed to address a wide range of medical conditions. This includes dermatological treatments, remedies for respiratory ailments, central nervous system disorders, digestive issues, and musculoskeletal complaints, alongside medications for the urinary and reproductive systems. Furthermore, the company provides disinfectants and a diverse portfolio of therapeutic agents covering areas such as sexual health, diabetes, cardiovascular diseases, anti-infectives, anti-parasitics, pain relief, antiseptics, and general men's and women's health. These pharmaceutical and health products are supplied in numerous formats, including creams, ointments, syrups, capsules, tablets, gels, lotions, sprays, topical solutions, and personal hygiene items like hand sanitizers, mouthwashes, and soaps. In addition to its proprietary product lines, MEPIC leverages its manufacturing capabilities to offer contract manufacturing services. The company also specializes in cosmetic products, general health aids, and nutritional supplements. Originally known as Middle East Chemical Products Factory Company, the organization officially rebranded to Middle East Pharmaceutical Industries Company in January 2006.
Aandeelprijs
$17.36
Laatst gesynchroniseerd: 2026-08-30
Marktkapitalisatie
$607.55M
Verandering (1 dag)
0.54%
Verandering (1 jaar)
-10.39%
Land
SA
Handel Middle East Pharmaceutical Industries Company (4016)

Categorie

Prijs 4016 met de marktkapitalisatie van B
Middle East Pharmaceutical Industries Company Middle East Pharmaceutical Industries Company
4016
$17.36
Marktkapitalisatie van Middle East Pharmaceutical Industries Company(4016)
Marktkapitalisatie: $607.55M
Vanaf August 2026 heeft Middle East Pharmaceutical Industries Company een marktkapitalisatie van $607.55M. Dit maakt Middle East Pharmaceutical Industries Company volgens onze gegevens het 12214th meest waardevolle bedrijf ter wereld op basis van marktkapitalisatie. De marktkapitalisatie is de totale marktwaarde van alle uitstaande aandelen van een beursgenoteerd bedrijf en wordt vaak gebruikt om de waarde van een bedrijf te meten.
Marktkapitalisatiegeschiedenis van Middle East Pharmaceutical Industries Company van 2024 tot 2026
4016 vergeleken met de top 5 populairste stocks
Prijs voor 4016 Aandeel B Marktkapitalisatie van B uitslagen
Middle East Pharmaceutical Industries Company Middle East Pharmaceutical Industries Company
$150,396 $607.55M
$5.264T +866,305.79%
Middle East Pharmaceutical Industries Company Middle East Pharmaceutical Industries Company
$134,322 $607.55M
$4.701T +773,706.04%
Middle East Pharmaceutical Industries Company Middle East Pharmaceutical Industries Company
$119,348 $607.55M
$4.177T +687,442.16%
Middle East Pharmaceutical Industries Company Middle East Pharmaceutical Industries Company
$109,069 $607.55M
$3.817T +628,224.76%
Middle East Pharmaceutical Industries Company Middle East Pharmaceutical Industries Company
$81,895.34 $607.55M
$2.866T +471,684.43%